Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal.
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2013
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 19 Feb 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 13 Dec 2011 Planned number of patients changed from 36 to 100 as reported by ClinicalTrials.gov.
- 22 Aug 2005 New trial record.